Hemispherx, GP Pharm in pact to market Alferon N Injection

Alferon N Injection is Hemispherx’s natural FDA approved interferon injection product for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries’ regulatory approval for any use of the product.

As per the agreement, Hemispherx will manufacture and supply Alferon N Injection to GP Pharm in Argentina under an exclusive sales, marketing, distribution and supply agreement.

Under this Agreement, GP Pharm will be responsible for gaining regulatory approval for each indication and commercializing Alferon N Injection(R) in Argentina.

Hemispherx has granted GP Pharm the right to expand its territory to include other Latin American countries based upon GP Pharm achieving regulatory approval and certain first sale performance milestones.

GP Pharm spokesperson Braver said that they are also excited to have the opportunity to market the FDA approved product, Alferon N Injection, a natural interferon with a proven track record of safety and historically demonstrated exceptional anti-viral capabilities, in Argentina and potentially throughout Latin America.